Targeting membrane proteins in their native environments - Mass spectrometry meets cell biology

Grant number: 221795/Z/20/Z

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2026
  • Known Financial Commitments (USD)

    $2,911,296.37
  • Funder

    Wellcome Trust
  • Principal Investigator

    Prof Dame Carol Robinson
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Oxford
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The overarching goal of my research is to understand the relationship between membrane proteins and their lipid surroundings. This is important since many membrane proteins are unable to retain their structure and function when extracted from their native environment and reconstituted into a membrane mimetic. Dynamic proteins, for example G-protein coupled receptors, solute carriers and sigma receptors, are intimately connected to their membrane environments and prone to loss of function and activity in detergent micelles. To overcome this disconnect we will develop and apply our mass spectrometry approaches to examine dynamic drug targets within their membrane context. Our key goals will be to challenge these receptors and transporters with agonists, antagonists, inhibitors and lipids effectively in situ. Examples include solute carriers which during tumour progression respond to the need for an altered metabolism by increasing expression. Analogous methods will be used to uncover the targets of mitochondrial and lysosomal therapies. Many of our research themes converge on consequences of the COVID-19 pandemic. While this remains an area of intense scientific scrutiny we will focus on the less-studied receptors and 'infection enhancers', and contribute to understanding the roles of lipids in the endocytosis and viral recognition pathways.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Following phospholipid transfer through the OmpF<sub>3</sub>-MlaA-MlaC lipid shuttle with native mass spectrometry.

Defining proteoform-specific interactions for drug targeting in a native cell signalling environment.

Traversing the drug discovery landscape using native mass spectrometry.

Coupling and Activation of the β1 Adrenergic Receptor - The Role of the Third Intracellular Loop.

Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA.

Native MS-guided lipidomics to define endogenous lipid microenvironments of eukaryotic receptors and transporters.

Phospholipids Differentially Regulate Ca2+ Binding to Synaptotagmin-1.

The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation.

Constitutive activation mechanism of a class C GPCR.